ETB

Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patie

Retrieved on: 
Tuesday, April 9, 2024
Head, HNSCC, Patient, Tumor microenvironment, Cancer, PRS, Neoplasm, PD-L1, Cytokine, Poster, Therapy, ETB, VEGF, Pharmaceutical industry

The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:

Key Points: 
  • The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:
    MT-6402 acts uniquely from other approved checkpoint agents.
  • MT-6402 depletes immunosuppressive PD-L1+ immune cells and tumor cells, activates a T-effector phenotype, and remodels the tumor microenvironment to restore T-cell surveillance of the tumor.
  • An early monotherapy efficacy signal in head and neck squamous cell carcinoma (HNSCC) was identified.
  • The patients remain on study at cycles 19 and 10, respectively (one cycle = 4 weeks), demonstrating the potential for durable monotherapy activity with MT-6402.

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

Retrieved on: 
Friday, March 29, 2024
Multiple myeloma, Private placement, Symantec Endpoint Protection, EGFR, CD8, Exercise, Disease, AML, HNSCC, CMV, Patient, Common, Tom Clancy's Ghost Recon, Neoplasm, Immunoglobulin A, Tumor microenvironment, Sale, Bristol Myers Squibb, Form 10-K, Cancer, MHC, PD-L1, Antibody, Interim, Therapy, MTD, Poster, Total, ETB, UPR, Pharmaceutical industry

The net loss attributable to common shareholders for the fourth quarter of 2023 was $3.9 million, or $0.73 per basic and diluted share.

Key Points: 
  • The net loss attributable to common shareholders for the fourth quarter of 2023 was $3.9 million, or $0.73 per basic and diluted share.
  • Revenues for the fourth quarter of 2023 were $7.0 million, compared to $2.6 million for the same period in 2022.
  • Revenues for the fourth quarter of 2023 were comprised of revenues from collaborative research and development agreements with Bristol-Myers Squibb and grant revenue.
  • For more details on MTEM’s financial results for 2023, refer to Form 10-K filed with the SEC.

Energy Toolbase Launches Groundbreaking Feature Enabling Grid Services and Utility Bill Savings Modeling for Solar + Storage Projects

Retrieved on: 
Monday, March 18, 2024
Database, Forecasting, DSGS, Software, C&I, Investment, Economics, ETB, Renewable energy

The ability to model grid services and utility bill savings empowers solar and storage projects to leverage a wide variety of value streams, enhancing overall project economics and reliability.

Key Points: 
  • The ability to model grid services and utility bill savings empowers solar and storage projects to leverage a wide variety of value streams, enhancing overall project economics and reliability.
  • This groundbreaking feature builds upon Energy Toolbase's advanced modeling technology, which includes optimization across multiple behind-the-meter value streams, rapid forecasting during simulation, and access to an unparalleled utility rates database.
  • This milestone is a paradigm shift in the commercial and industrial (C&I) solar and energy storage modeling landscape, making Energy Toolbase the first in the industry to offer users the ability to model grid services and utility bill savings.
  • "At Energy Toolbase, we are constantly pushing the boundaries of what's possible with C&I solar and energy storage modeling," said Nathan Gutzmann, Product Manager of Acumen EMS™ at Energy Toolbase.

Energy Toolbase Partners with Station A to Catalyze Commercial Solar-Plus-Storage Deployment Across the US

Retrieved on: 
Wednesday, January 31, 2024
Partnership, Improper integral, ETB, Construction

STUART, Fla., Jan. 31, 2024 /PRNewswire/ -- Energy Toolbase (ETB), a leading provider of software solutions for financial analysis of solar and energy storage projects, energy management system controls, and operational monitoring, announced a partnership with Station A, a leading clean energy marketplace, to enable commercial & industrial companies to competitively deploy optimized clean energy solutions on their sites.

Key Points: 
  • In May 2023, Energy Toolbase launched its Enterprise Services consulting division, which enables commercial customers and project developers to outsource their system design and proposal development to ETB's in-house team of domain experts.
  • The new partnership between Energy Toolbase and Station A takes a project into the next stage of procurement and contracting by allowing the client to obtain competitive installation quotes for their specified project.
  • Station A enables any company to list clean energy projects in its marketplace to receive competitive offers.
  • To date, Station A has one of the largest provider audiences in the country, with approximately 2,500+ active provider accounts.

Energy Toolbase Expands to Solar Monitoring

Retrieved on: 
Thursday, November 16, 2023
Solar energy, Investment, Growth, Economics, Database, ETB, Weather, Software, Renewable energy

STUART, Fla., Nov. 16, 2023 /PRNewswire/ -- Energy Toolbase, a leading provider of software for solar + energy storage analysis, proposal generation, and intelligent energy management systems, announced the expansion of its software offerings to solar-only monitoring. ETB Monitor is a cutting-edge platform designed to provide energy professionals and asset managers with comprehensive economic and solar energy monitoring, enabling them to maximize their project's value.

Key Points: 
  • STUART, Fla., Nov. 16, 2023 /PRNewswire/ -- Energy Toolbase, a leading provider of software for solar + energy storage analysis, proposal generation, and intelligent energy management systems, announced the expansion of its software offerings to solar-only monitoring.
  • ETB Monitor is a cutting-edge platform designed to provide energy professionals and asset managers with comprehensive economic and solar energy monitoring, enabling them to maximize their project's value.
  • ETB Monitor is available as a standalone platform or as an integrated solution with Energy Toolbase's existing software suite, ETB Developer , which specializes in solar and energy storage proposal analysis.
  • "We are excited to offer ETB Monitor to our customers, providing them with the tools they need to efficiently manage their solar energy projects," said John Gurski, Founder and President of Energy Toolbase.

Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update

Retrieved on: 
Thursday, August 10, 2023
Intellectual property, PR, Therapy, PD, Symantec Endpoint Protection, Bank statement, Neoplasm, Immunomodulatory imide drug, Food, Aes, Food and Drug Administration, RECIST, MHC, Cancer, Bristol Myers Squibb, NSCLC, Immunoglobulin A, Bone disease, Sale, Monocyte, CD8, HIV disease progression rates, MDSC, PD-L1, Patient, CMV, TME, Biology, BMS, Private placement, FDA, ETB, Pembrolizumab, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Partial-response maximum-likelihood, WalletHub, BCMA, Safety, Conference, Pharmaceutical industry, Nursing, Medical imaging, Security (finance), Vaccine, Medical device, Palladium

Revenues for the second quarter of 2023 were $6.9 million, compared to $4.4 million for the same period in 2022.

Key Points: 
  • Revenues for the second quarter of 2023 were $6.9 million, compared to $4.4 million for the same period in 2022.
  • Revenues for the second quarter of 2023 were comprised of revenues from collaborative research and development agreements with Bristol Myers Squibb and grant revenue from CPRIT.
  • Total research and development expenses for the second quarter of 2023 were $13.4 million, compared with $21.4 million for the same period in 2022.
  • Total general and administrative expenses for the second quarter of 2023 were $5.2 million, compared with $6.6 million for the same period in 2022.

Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Retrieved on: 
Friday, May 26, 2023
Therapy, Neoplasm, American Society of Clinical Oncology, MHC, Cancer, Capillary leak syndrome, CD8, PD-L1, Patient, CST, CMV, Poster, ETB, Society, Safety, Vaccine

One-on-one meetings may be scheduled directly with Molecular Templates.

Key Points: 
  • One-on-one meetings may be scheduled directly with Molecular Templates.
  • The poster will highlight interim efficacy and safety data on MT-6402, MTEM’s ETB program designed to activate T-cells through direct cell-kill of immunosuppressive PD-L1+ immune cells.
  • MT-6402 continues to demonstrate pharmacodynamic effects and monotherapy activity in heavily pre-treated checkpoint therapy experienced patients.
  • To date, no instances of capillary leak syndrome or other manifestations of innate immunity have been observed with any next-generation ETB.

Eaton Vance Management Announces Portfolio Management Teams of Certain Closed-End Funds

Retrieved on: 
Friday, May 26, 2023
Banking, Professional Services, Finance, Exercise, Mutual fund, ETW, ETV, Head, ETB, Investment, NYSE, Risk, Vance, Security (finance), Fund

Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund (NYSE: ETW)

Key Points: 
  • Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund (NYSE: ETW)
    Thomas C. Seto is a managing director and head of investment management at Parametric Portfolio Associates LLC, sub-adviser to ETB, ETV and ETW.
  • Shares of closed-end funds often trade at a discount from their net asset value.
  • Before investing, prospective investors should consider carefully the Fund’s investment objective, risks, charges and expenses.
  • Additional information about the Funds, including performance and portfolio characteristic information, is available at www.eatonvance.com .

Renewable Developer Taps Green Bridge Energy and Energy Toolbase for Solar PPA Financing at Non-Profit, Private College

Retrieved on: 
Wednesday, May 24, 2023
Partnership, Solar System, EV, Engineering, Developer, Points of the compass, Electricity, Carbon, Kangaroo Point Green Bridge, Professional, RISE, Power purchase agreement, ESG, PPA, ETB, C&I, Renewable energy, Green Bridge

STUART, Fla., May 24, 2023 /PRNewswire/ -- Energy Toolbase and Green Bridge Energy have partnered to provide Northeast-based commercial solar developer RISE with financing for a solar system to power a non-profit, private college. The developer tapped Green Bridge Energy's financing solution within the ETB Developer platform to provide an indicative Power Purchase Agreement (PPA) quote for the system that will finance its entirety.

Key Points: 
  • STUART, Fla., May 24, 2023 /PRNewswire/ -- Energy Toolbase and Green Bridge Energy have partnered to provide Northeast-based commercial solar developer RISE with financing for a solar system to power a non-profit, private college.
  • The developer tapped Green Bridge Energy's financing solution within the ETB Developer platform to provide an indicative Power Purchase Agreement (PPA) quote for the system that will finance its entirety.
  • The Green Bridge Energy financing integration is available to all ETB Developer platform users, allowing developers access to instantly generate PPA quotes for C&I and non-profit solar + storage projects without leaving the platform.
  • "Working with Green Bridge to provide financing quotes within ETB Developer has been a game-changer for our users getting projects sold faster," said Matt Cimo, Manager of the Developer Channel at Energy Toolbase.

Quest Diagnostics Reports First Quarter 2023 Financial Results; Updates Guidance for Full Year 2023

Retrieved on: 
Thursday, April 27, 2023
Security (finance), Health equity, Quest Diagnostics, ETB, GAAP, Table, Risk, Bank

Non-GAAP adjusted measures are presented because management believes those measures are useful adjuncts to GAAP results.

Key Points: 
  • Non-GAAP adjusted measures are presented because management believes those measures are useful adjuncts to GAAP results.
  • Non-GAAP adjusted measures should not be considered as an alternative to the corresponding measures determined under GAAP.
  • Quest Diagnostics will hold its quarterly conference call to discuss financial results beginning at 8:30 a.m. Eastern Time today.
  • Anyone listening to the call is encouraged to read our periodic reports, on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.